Clinical and molecular characteristics of estrogen receptor‐positive ultralow risk breast cancer tumors identified by the 70‐gene signature

The metastatic potential of estrogen receptor (ER)‐positive breast cancers is heterogeneous and distant recurrences occur months to decades after primary diagnosis. We have previously shown that patients with tumors classified as ultralow risk by the 70‐gene signature have a minimal long‐term risk o...

Descripción completa

Detalles Bibliográficos
Autores principales: Johansson, Annelie, Yu, Nancy Y., Iftimi, Adina, Tobin, Nicholas P., van 't Veer, Laura, Nordenskjöld, Bo, Benz, Christopher C., Fornander, Tommy, Perez‐Tenorio, Gizeh, Stål, Olle, Esserman, Laura J., Yau, Christina, Lindström, Linda S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Tumor Markers and Signatures
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083187/
https://www.ncbi.nlm.nih.gov/pubmed/35179782
http://dx.doi.org/10.1002/ijc.33969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083187/
https://www.ncbi.nlm.nih.gov/pubmed/35179782
http://dx.doi.org/10.1002/ijc.33969

Ejemplares similares